跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
NOREPINEPHRINE BITARTRATE INJECTION
Authorized
STANDARD
NOREPINEPHRINE BITARTRATE INJECTION
Juno Pharmaceuticals Corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e6c6cfb4837aa1e1
Company
Juno Pharmaceuticals Corp.
Type
Standard
Approval Details
Approval Id
e6c6cfb4837aa1e1
Drug Approval Canada Name
NOREPINEPHRINE BITARTRATE INJECTION
Product Name
NOREPINEPHRINE BITARTRATE INJECTION
Status
Marketed
Status Date
2024-04-30
Original Market Date
2024-04-30
Din
02540630
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
12:12.12
Atc Original
C01CA03 NOREPINEPHRINE
Atc Name
c 01 ca 03
Aig Number
0131301001
Company Name
Juno Pharmaceuticals Corp.
Company Address
402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
1 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e6c6cfb4837aa1e1
Type
Standard
Back to Health Canada Approvals
NOREPINEPHRINE BITARTRATE INJECTION - Health Canada Drug Approval Details